In Your Genes: Not Can We, But Should We? (HyFlex: Zoom)

In Your Genes: Not Can We, But Should We? (HyFlex: Zoom)

Spring (4-8 hours) | Available (Membership Required)

Online Lebanon, NH 03766 United States
Online Meeting
5/18/2026-6/15/2026
View Schedule
$50.00

To assist you in preparing for this Course, we have provided a link to the setup / test pages from the conference provider. If you have never used this conference service before please click on the link below so that your PC or device will be ready to participate in this Course.

In Your Genes: Not Can We, But Should We? (HyFlex: Zoom)

Spring (4-8 hours) | Available (Membership Required)

This is the Zoom registration option for this course!

Back once again with all new content, this course will look at the advances in medical- and bio- technology that have occurred over the last year, driven by our understanding of genetics and molecular biology.

While scientists and regulators are coming together to chart a pathway for the development and approval of treatments for rare genetic diseases, ongoing clinical studies of new treatment technologies have had both high and low moments. And artificial intelligence promises or, depending on your point of view, threatens to revolutionize both healthcare and the discovery of new therapeutic gents. But technological advances often bump up against established norms.

We shall look at advances in cell engineering and together discuss where boundaries should be drawn, not to be crossed. We will also remember the contributions of several ‘greats’ in the field who died in the last year. Whether you’re a returning participant or new to the field, this course is perfect for anyone curious about the human genome and the groundbreaking genetic technologies shaping our world.

This course will combine lecture with class discussions.

This is a four-session course (8 hours total).


  • There are no required books for this course.

    No class May 25th.


Sim, Iain
Iain Sim

Iain Sim has a PhD degree in Microbiology and 30+ years of R&D experience in the pharmaceutical and biotech industry, working on diagnostics, treatments, and vaccines in the fields of virology, oncology, and immunology. He has been leading Osher courses on the human genome and advances in genetic technology since 2012, interspersing science courses with studies on notable historical figures.